Compounds > n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride
Page last updated: 2024-09-04

n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride and levodopa

n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride)		Trials
(n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride)		Recent Studies (post-2010)
(n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride)		Studies
(levodopa)		Trials
(levodopa)		Recent Studies (post-2010) (levodopa)
60017,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomyn-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Finberg, JP; Youdim, MB1

Other Studies

1 other study(ies) available for n-methyl-n-propargyl-(1-indanyl)-ammonium hydrochloride and levodopa

ArticleYear
MAO type B inhibitors as adjunct to L-dopa therapy.
    Advances in neurology, 1987, Volume: 45

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alkynes; Animals; Brain; Drug Therapy, Combination; Humans; Indans; Isoenzymes; Levodopa; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Receptors, Dopamine; Selegiline; Structure-Activity Relationship; Tyramine

1987